SEARCH

SEARCH BY CITATION

References

  • 1
    Elenitoba-Johnson KS , Jaffe ES . Lymphoproliferative disorders associated with congenital immunodeficiencies . Semin Diagn Pathol 1997 ; 14 : 3547 .
  • 2
    Kamel OW . Iatrogenic lymphoproliferative disorders in nontransplantation settings . Semin Diagn Pathol 1997 ; 14 : 2734 .
  • 3
    Starzl TE , Nalesnik MA , Porter KA et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy . Lancet 1984 ; 1 : 583587 .
  • 4
    Nalesnik MA . Lymphoproliferative disease in organ transplant recipients . Springer Semin Immunopathol 1991 ; 13 : 199216 .
  • 5
    Cohen JI . Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency . Medicine (Baltimore) 1991 ; 70 : 137160 .
  • 6
    Penn I . Posttransplantation de novo tumors in liver allograft recipients . Liver Transpl Surg 1996 ; 2 : 5259 .
  • 7
    Nalesnik MA , Makowka L , Starzl TE . The diagnosis and treatment of posttransplant lymphoproliferative disorders . Curr Probl Surg 1988 ; 25 : 367472 .
  • 8
    Reams BD , McAdams HP , Howell DN , Steele MP , Davis RD , Palmer SM . Posttransplant lymphoproliferative disorder: Incidence, presentation, and response to treatment in lung transplant recipients . Chest 2003 ; 124 : 12421249 .
  • 9
    Reyes J , Green M , Bueno J et al. Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation . Transplant Proc 1996 ; 28 : 27682769 .
  • 10
    Leblond V , Choquet S . Lymphoproliferative disorders after liver transplantation . J Hepatol 2004 ; 40 : 728735 .
  • 11
    Birkeland SA , Hamilton-Dutoit S . Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se? Transplantation 2003 ; 76 : 984988 .
  • 12
    Thorley-Lawson DA , Gross A . Persistence of the Epstein-Barr virus and the origins of associated lymphomas . N Engl J Med 2004 ; 350 : 13281337 .
  • 13
    Bustami RT , Ojo AO , Wolfe RA et al. Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients . Am J Transplant 2004 ; 4 : 8793 .
  • 14
    Cherikh WS , Kauffman HM , McBride MA , Maghirang J , Swinnen LJ , Hanto DW . Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation . Transplantation 2003 ; 76 : 12891293 .
  • 15
    Cohen JI . Epstein-Barr virus infection . N Engl J Med 2000 ; 343 : 481492 .
  • 16
    Leblond V , Davi F , Charlotte F et al. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: A distinct entity? J Clin Oncol Jun 1998 ; 16 : 20522059 .
  • 17
    Nelson BP , Nalesnik MA , Bahler DW , Locker J , Fung JJ , Swerdlow SH . Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: A distinct entity? Am J Surg Pathol 2000 ; 24 : 375385 .
  • 18
    Dotti G , Fiocchi R , Motta T et al. Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant . Transplantation Mar 15 2000 ; 69 : 827833 .
  • 19
    Swerdlow AJ , Higgins CD , Hunt BJ et al. Risk of lymphoid neoplasia after cardiothoracic transplantation. A cohort study of the relation to Epstein-Barr virus . Transplantation 2000 ; 69 : 897904 .
  • 20
    Morrison VA , Dunn DL , Manivel JC , Gajl-Peczalska KJ , Peterson BA . Clinical characteristics of post-transplant lymphoproliferative disorders . Am J Med 1994 ; 97 : 1424 .
  • 21
    McLaughlin K , Wajstaub S , Marotta P et al. Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C . Liver Transpl 2000 ; 6 : 570574 .
  • 22
    Duvoux C , Pageaux GP , Vanlemmens C et al. Risk factors for lymphoproliferative disorders after liver transplantation in adults: An analysis of 480 patients . Transplantation 2002 ; 74 : 11031109 .
  • 23
    Jain A , Nalesnik M , Reyes J et al. Posttransplant lymphoproliferative disorders in liver transplantation: A 20-year experience . Ann Surg 2002 ; 236 : 429436 ; discussion 436–427 .
  • 24
    Zein NN , Perez RG , Wiesner RH . Hepatitis C virus infection and lymphoproliferative disorders after liver transplantation . Hepatology 2000 ; 31 : 808809 .
  • 25
    Vallejo GH , Romero CJ , de Vicente JC . Incidence and risk factors for cancer after liver transplantation . Crit Rev Oncol Hematol 2005 .
  • 26
    Harris N , Swerdlow S , Frizzera G , Knowles D . Post-transplant lymphoproliferative disorders . In : Jaffe E , Harris N , Stein H , Vardiman J ( eds ), World Health Organization classification of tumours. Pathology and genetics of tumours of hematopoietic and lymphoid tissues . Lyon : IARC Press , 2001 : 264269 .
  • 27
    Macon WR , Levy NB , Kurtin PJ et al. Hepatosplenic alphabeta T-cell lymphomas: A report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas . Am J Surg Pathol 2001 ; 25 : 285296 .
  • 28
    Lust JA . Molecular genetics and lymphoproliferative disorders . J Clin Lab Anal 1996 ; 10 : 359367 .
  • 29
    Gooley TA , Leisenring W , Crowley J , Storer BE . Estimation of failure probabilities in the presence of competing risks: New representations of old estimators . Stat Med 1999 ; 18 : 695706 .
  • 30
    Kalbfleish D , Prentice R . The statistical analysis of failure time data . New York , NY : Wiley , 2002 .
  • 31
    Paya CV , Fung JJ , Nalesnik MA et al. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting . Transplantation 1999 ; 68 : 15171525 .
  • 32
    Ghobrial IM , Habermann TM , Macon WR et al. Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: Are they two different diseases? Transplantation 2005 ; 79 : 244247 .
  • 33
    Ciancio G , Siquijor AP , Burke GW et al. Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era . Clin Transplant 1997 ; 11 : 243249 .
  • 34
    Dantal J , Hourmant M , Cantarovich D et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporin regimens . Lancet 1998 ; 351 : 623628 .
  • 35
    Swinnen LJ , Costanzo-Nordin MR , Fisher SG et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients . N Engl J Med 1990 ; 323 : 17231728 .
  • 36
    Salas M , Hofman A , Stricker BH . Confounding by indication: An example of variation in the use of epidemiologic terminology . Am J Epidemiol 1999 ; 149 : 981983 .
  • 37
    Wiesner RH , Demetris AJ , Belle SH et al. Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome . Hepatology 1998 ; 28 : 638645 .
  • 38
    Klungel OH , Martens EP , Psaty BM et al. Methods to assess intended effects of drug treatment in observational studies are reviewed . J Clin Epidemiol 2004 ; 57 : 12231231 .
  • 39
    Gross TG , Steinbuch M , DeFor T et al. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: Risk factors, treatment and outcome . Bone Marrow Transplant 1999 ; 23 : 251258 .
  • 40
    Shpilberg O , Wilson J , Whiteside TL , Herberman RB . Pre-transplant immunological profile and risk factor analysis of post-transplant lymphoproliferative disease development: The results of a nested matched case-control study. The University of Pittsburgh PTLD Study Group . Leuk Lymphoma 1999 ; 36 : 109121 .
  • 41
    Walker RC , Marshall WF , Strickler JG et al. Pretransplantation assessment of the risk of lymphoproliferative disorder . Clin Infect Dis 1995 ; 20 : 13461353 .
  • 42
    Funch DP , Walker AM , Schneider G , Ziyadeh NJ , Pescovitz MD . Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients . Am J Transplant 2005 ; 5 : 28942900 .
  • 43
    Mansfield ES , Sarwal MM . Arraying the orchestration of allograft pathology . Am J Transplant 2004 ; 4 : 853862 .